Take Action: Tell the FDA Your Thoughts on Sotagliflozin
New T1D Equity Framework Partnership with Medtronic Inc.
CDC Adds T1D as Medical Condition Associated with Higher Risk for Severe COVID-19
The Centers for Disease Control (CDC) has added type 1 diabetes (T1D) as one of the medical conditions associated with…
DiabetesMine: Adjusting Basal (Background) Insulin for Max Impact
“You only need a few days of living with type 1 diabetes (T1D) under your belt to realize just how…
Panel Discussion on Health Inequities in Type 1 Diabetes
Tidepool Completes FDA 510(k) Submission of Tidepool Loop
Open Source Diabetes Nonprofit Submits Automated Insulin Dosing App for iPhone for FDA Review Tidepool, a 501(c)3 nonprofit, today announced…
Racial Inequities Among People with Type 1 Diabetes and COVID-19
T1D Exchange is honored to have our recent study results examining racial inequities among people with type 1 diabetes and COVID-19 included in two major publications. Structural and systemic…
2020 Highlights from the T1D Exchange Quality Improvement Collaborative
While the world was put on hold due to COVID-19, we did not press pause on type 1 diabetes research….
Join our mailing list for more about T1D